A commentary on some of the best research in this field published in the past year
An integral part of a treatment plan for managing sexual dysfunction in women is the use of hormonal and pharmaceutical agents, a variety of which are available.
A debate at ACOG 2017 looks at whether cervical insufficiency should be abandoned as a diagnosis. Plus: A study presented at ACOG 2017 examines whether human papillomavirus is linked to preterm birth?
Results from a longitudinal study suggest that bacteria in the cervicovaginal microbiome (CVM) may play a role in risk of progression of high-risk human papillomavirus (HR-HPV) to cervical precancer.
The Foley balloon is a tried and true mechanical method for cervical ripening
Designed specifically for new mothers, Cool Mom gel packs offer a soft, non-toxic, and eco-friendly solution to postpartum discomfort, combining innovation with practical comfort.
Ob/gyns can take simple steps to help patients understand their personal health information, promoting better outcomes.
A review of the risks, benefits, and indications for appropriate referral of fetal echocardiography
Expert commentary on Practice Bulletin No. 184: Vaginal Birth After Cesarean Delivery.
As value in healthcare becomes an increasing priority for healthcare systems, ERPs will play a vital role in improving the care provided to patients.
Review the steps in a cesarean and take a moment to examine the best available evidence for performing the procedure.
Review the steps in a cesarean and take a moment to examine the best available evidence for performing the procedure.
If a patient exhibits at least two of these 11 behaviors, it may signal a problematic pattern of opioid use leading to clinically significant impairment or distress.
If a patient exhibits at least two of these 11 behaviors, it may signal a problematic pattern of opioid use leading to clinically significant impairment or distress.
Providers should be discussing Zika with their patients and educating them about preventive strategies as well as offering screening and testing to relevant populations of pregnant women.
View the latest recommendations from the Society for Maternal-Fetal Medicine on anticoagulation in pregnant patients with cardiac disease.
SMFM Consult Series #56: Hepatitis C in pregnancy: updated screening, treatment, and management guidelines.
In the United States, 1% to 2.5% of pregnant women are infected with hepatitis C virus (HCV), which carries an approximately 5% risk of transmission from mother to infant. HCV can be transmitted to an infant in utero or during the peripartum period.
SMFM Consult Series #56: Hepatitis C in pregnancy: updated screening, treatment, and management guidelines.
Hypertensive disorders of pregnancy are among the leading contributors to maternal mortality worldwide, but up to 60% of hypertension-related maternal deaths are potentially preventable.
Hypertensive disorders of pregnancy are among the leading contributors to maternal mortality worldwide, but up to 60% of hypertension-related maternal deaths are potentially preventable.
To improve health outcomes, today’s physicians must be able to communicate effectively with their patients. One approach many experts encourage physicians to use is motivational interviewing (MI), a series of techniques to get at the root of patient concerns and help encourage them to make healthy behavior changes.
Expert commentary on Committee Opinion 686: Breast and Labial Surgery in Adolescents.
Recognition and management of sepsis and septic shock in pregnant women remain a challenge, despite several advances made in the non-pregnant patient population. This article will review how to recognize sepsis and key principles for management of the condition in pregnant patients.
Recognition and management of sepsis and septic shock in pregnant women remain a challenge, despite several advances made in the non-pregnant patient population. This article will review how to recognize sepsis and key principles for management of the condition in pregnant patients.
Introducing Contemporary OB/GYN® Editorial Advisory Board member, Laura E. Riley, MD.